Article Details
Retrieved on: 2024-02-23 15:13:25
Tags for this article:
Click the tags to see associated articles and topics
Summary
Enveric Biosciences, facing financial challenges, sells a cancer-related patent portfolio to focus on developing mental health treatments, such as psilocybin-based neuroplastogens, under the leadership of CEO Joseph Tucker.
Article found on: www.greenmarketreport.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here